Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
High-Dose Methylprednisolone for Caustic Esophageal Burns
NCT02002078Phase 4Completed
- Sponsor
- Şişli Hamidiye Etfal Training and Research Hospital
- Start
- Feb 2007
- Primary completion
- Dec 2008
- Modality
- Orthosteric Ligands
01
Overview
A Phase 4 trial of methylprednisolone in caustic esophagitis, sponsored by Şişli Hamidiye Etfal Training and Research Hospital. Started Feb 2007; status: completed.
02
Drugs
methylprednisolone
03
Conditions
caustic esophagitis
Beyond the preview
Go deeper on NCT02002078.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02002078.